Concepedia

Mohammad Atefi

MA

24

Publications

5.4K

Citations

20

H-Index

2009

Active since

Affiliations

University of California, Los Angeles(Current)

UCLA Jonsson Comprehensive Cancer Center

Shiraz University of Medical Sciences

University of Colorado Cancer Center

California NanoSystems Institute

Mohammad Atefi is an author at University of California, Los Angeles specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2009–2018

24

Publications

24

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

Poulikos I. Poulikakos, Yogindra Persaud, Manickam Janakiraman et al. · Nature · 2011 · 1.4K citations

, , +1

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Richard S. Finn, Judy Dering, Dylan Conklin et al. · Breast Cancer Research · 2009 · 1.4K citations · Full text

Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress

Jennifer Tsoi, Lídia Robert, Kim H.T. Paraiso et al. · Cancer Cell · 2018 · 909 citations · Full text

, , +9

Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma

Mohammad Atefi, Earl Avramis, Amanda Lassen et al. · Clinical Cancer Research · 2014 · 325 citations · Full text

Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway

Mohammad Atefi, Erika von Euw, Narsis Attar et al. · PLoS ONE · 2011 · 222 citations · Full text

Rows per page

1–5 of 24